Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javle

Showing results (241-250 of 343) with videos related to

Pageof 35
Sort By:
Plos One|December 24, 2014
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implicationsChaitanya R Churi, Rachna Shroff, Ying Wang, et al.
JCO Precision Oncology|September 14, 2020
Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNANora S Sánchez, Michael P Kahle, Ann Marie Bailey, et al.
Cancer|March 7, 2023
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumorsFilip Janku, Milind M Javle, Shiraj Sen, et al.
JCO Precision Oncology|February 9, 2022
Cholangiocarcinoma With <i>FGFR</i> Genetic Aberrations: A Unique Clinical PhenotypeApurva Jain, Mitesh J Borad, Robin Kate Kelley, et al.
JCO Precision Oncology|September 3, 2021
Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or CholangiocarcinomaKarthikeyan Murugesan, Radwa Sharaf, Meagan Montesion, et al.
JCO Precision Oncology|September 14, 2020
Intrahepatic Cholangiocarcinoma: Genomic Heterogeneity Between Eastern and Western PatientsJingyu Cao, Jing Hu, Siqin Liu, et al.
The Lancet. Gastroenterology & Hepatology|December 5, 2025
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trialMilind Javle, Christos Fountzilas, Chih-Yi Liao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2023
Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with CholangiocarcinomaRikita I Hatia, Madhulika Eluri, Ernest T Hawk, et al.
Journal of Gastrointestinal Oncology|November 12, 2025
Safety and efficacy of liver-directed radiotherapy after chemoimmunotherapy for advanced cholangiocarcinoma: an early report from a large tertiary cancer centerAbdulmoiz Asif, Abdulmoid Asif, Michael K Rooney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic CancerSeyed Pairawan, Kenneth R Hess, Filip Janku, et al.
Pageof 35

Showing results (241-250 of 343) with videos related to

Sort By:
Pageof 35
Plos One|December 24, 2014
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implicationsChaitanya R Churi, Rachna Shroff, Ying Wang, et al.
JCO Precision Oncology|September 14, 2020
Identification of Actionable Genomic Alterations Using Circulating Cell-Free DNANora S Sánchez, Michael P Kahle, Ann Marie Bailey, et al.
Cancer|March 7, 2023
A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumorsFilip Janku, Milind M Javle, Shiraj Sen, et al.
JCO Precision Oncology|February 9, 2022
Cholangiocarcinoma With <i>FGFR</i> Genetic Aberrations: A Unique Clinical PhenotypeApurva Jain, Mitesh J Borad, Robin Kate Kelley, et al.
JCO Precision Oncology|September 3, 2021
Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or CholangiocarcinomaKarthikeyan Murugesan, Radwa Sharaf, Meagan Montesion, et al.
JCO Precision Oncology|September 14, 2020
Intrahepatic Cholangiocarcinoma: Genomic Heterogeneity Between Eastern and Western PatientsJingyu Cao, Jing Hu, Siqin Liu, et al.
The Lancet. Gastroenterology & Hepatology|December 5, 2025
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trialMilind Javle, Christos Fountzilas, Chih-Yi Liao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2023
Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with CholangiocarcinomaRikita I Hatia, Madhulika Eluri, Ernest T Hawk, et al.
Journal of Gastrointestinal Oncology|November 12, 2025
Safety and efficacy of liver-directed radiotherapy after chemoimmunotherapy for advanced cholangiocarcinoma: an early report from a large tertiary cancer centerAbdulmoiz Asif, Abdulmoid Asif, Michael K Rooney, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2019
Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic CancerSeyed Pairawan, Kenneth R Hess, Filip Janku, et al.
Pageof 35